BrainStorm Cell Therapeutics Announces First Quarter 2015 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/20/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. RTB
6. ONON
7. AAPL
8. ACN
9. AZN
10. SPCX

Go back to BrainStorm Cell Therapeutics Announces First Quarter 2015 Financial Results and Provides Corporate Update

Brainstorm Cell Therapeutics (BCLI) Tops Q1 EPS by 1c

May 14, 2015 7:10 AM EDT

Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).

ony Fiorino, MD, PhD, Chief Executive Officer of BrainStorm, stated, "During the first quarter, we made good progress in our amyotrophic lateral sclerosis clinical development program for NurOwn®. We started the quarter by reporting positive top line results... More